EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Lipid-Based Nanomedicines for the Treatment of Bacterial Respiratory Infections: Current State and New Perspectives

Eva María Arroyo-Urea iD, María Lázaro-Díez iD, Junkal Garmendia iD, Fernando Herranz iD, Ana González-Paredes iD

Nanomedicine · 2024

DOI: 10.2217/nnm-2023-0243 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nanomedicine, 2024. Verfasst von Eva María Arroyo-Urea und 4 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Química Médica, Consejo Superior de Investigaciones Científicas (IQM-CSIC), C/ Juan de la Cierva, 3, 28006, Madrid, Spain. Hauptthemen laut MEDLINE: Bacterial Infections, Respiratory Tract Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 175 Literaturangaben. Gefördert von: Comunidad de Madrid (Spain), Nanomedicine CSIC Hub, Spanish Ministry of Science and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global threat posed by antimicrobial resistance demands urgent action and the development of effective drugs. Lower respiratory tract infections remain the deadliest communicable disease worldwide, often challenging to treat due to the presence of bacteria that form recalcitrant biofilms. There is consensus that novel anti-infectives with reduced resistance compared with conventional antibiotics are needed, leading to extensive research on innovative antibacterial agents. This review explores the recent progress in lipid-based nanomedicines developed to counteract bacterial respiratory infections, especially those involving biofilm growth; focuses on improved drug bioavailability and targeting and highlights novel strategies to enhance treatment efficacy while emphasizing the importance of continued research in this dynamic field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacterial InfectionsRespiratory Tract InfectionsHumansNanomedicineAnti-Bacterial AgentsBiofilmsLipids

Stichwörter der Autor:innen

antimicrobial resistancebacterial respiratory infectionsbiofilmdrug deliverylipid nanoparticlesnanomedicinetargeting

Substanzen

Anti-Bacterial AgentsLipids

Autor:innen und Institutionen

  • Instituto de Química Médica, Consejo Superior de Investigaciones Científicas (IQM-CSIC), C/ Juan de la Cierva, 3, 28006, Madrid, Spain.
  • Instituto de Agrobiotecnología, Consejo Superior de Investigaciones Científicas y Gobierno de Navarra (IdAB-CSIC), Av. de Pamplona, 123, 31192, Mutilva, Navarra, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Av. Monforte de Lemos, 3-5, 28029, Madrid, Spain.

ORCID-Profile: Eva María Arroyo-Urea, María Lázaro-Díez, Junkal Garmendia, Fernando Herranz, Ana González-Paredes

Förderung

  • Comunidad de Madrid (Spain)
  • Nanomedicine CSIC Hub
  • Spanish Ministry of Science and Innovation
  • Spanish Society of Pulmonology and Thoracic Surgery
  • Gobierno de Navarra

Zitieren

APA

Arroyo-Urea, E. M., Lázaro-Díez, M., Garmendia, J., Herranz, F., & González-Paredes, A. (2024). Lipid-Based Nanomedicines for the Treatment of Bacterial Respiratory Infections: Current State and New Perspectives. Nanomedicine. https://doi.org/10.2217/nnm-2023-0243

Vancouver

Arroyo-Urea EM, Lázaro-Díez M, Garmendia J, Herranz F, González-Paredes A. Lipid-Based Nanomedicines for the Treatment of Bacterial Respiratory Infections: Current State and New Perspectives. Nanomedicine. 2024. doi:10.2217/nnm-2023-0243

BibTeX
@article{ArroyoUrea2024,
  author = {Arroyo-Urea, Eva María and Lázaro-Díez, María and Garmendia, Junkal and Herranz, Fernando and González-Paredes, Ana},
  title = {Lipid-Based Nanomedicines for the Treatment of Bacterial Respiratory Infections: Current State and New Perspectives},
  journal = {Nanomedicine},
  year = {2024},
  doi = {10.2217/nnm-2023-0243}
}
Kostenlos starten →